STING1 and metabolic dysfunction-associated steatohepatitis: Considering the important role of gut microbiota in both preclinical NAFLD/NASH models and patients with NASH, the role of STING and gut microbiota interaction in modulating intrahepatic inflammation is still significant to explore.